These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4832585)

  • 1. Effect of long-term allopurinol administration on serial GFR in normotensive and hypertensive hyperuricemic subjects.
    Rosenfeld JB
    Adv Exp Med Biol; 1974; 41():581-96. PubMed ID: 4832585
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment with allopurinol in gout and hyperuricemic renal disease].
    Hood B; Olander R
    Lakartidningen; 1973 Mar; 70(13):1297-300. PubMed ID: 4699017
    [No Abstract]   [Full Text] [Related]  

  • 3. Tienilic acid in the treatment of gout and hypertension.
    Gibson T; Potter C; Simmonds HA; Rogers V; Gleadle RI
    Adv Exp Med Biol; 1980; 122A():277-82. PubMed ID: 7424646
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of uric acid pool size and turnover rate.
    Scott JT; Holloway VP; Glass HI; Arnot RN
    Ann Rheum Dis; 1969 Jul; 28(4):366-73. PubMed ID: 5794063
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions.
    Kanbay M; Ozkara A; Selcoki Y; Isik B; Turgut F; Bavbek N; Uz E; Akcay A; Yigitoglu R; Covic A
    Int Urol Nephrol; 2007; 39(4):1227-33. PubMed ID: 17701281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Milurit on decreasing hyperuricaemia in hypertensive patients.
    Réthyly E; Pálfy A
    Ther Hung; 1974; 22(4):183-6. PubMed ID: 4465964
    [No Abstract]   [Full Text] [Related]  

  • 7. [Uric acid and its metabolism].
    Kissel P; Royer R
    Presse Med (1893); 1968 Dec; 76(49):2317-8. PubMed ID: 5737248
    [No Abstract]   [Full Text] [Related]  

  • 8. Allopurinol hypersensitivity in a patient with coexistent systemic lupus erythematosus and tophaceous gout.
    McDonald J; Fam AG; Paton T; Senn J
    J Rheumatol; 1988; 15(5):865-8. PubMed ID: 3172103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tienilic acid in hypertension with hyperuricaemia.
    Zacharias F
    Postgrad Med J; 1979; 55 Suppl 3():81-4. PubMed ID: 504043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Observations on a random group of gout patients].
    Einaudi G; Marrazzi G; Pecchiura G
    Reumatismo; 1972; 24(1):21-9. PubMed ID: 4671625
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: a phase 3, multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study.
    Hosoya T; Ogawa Y; Hashimoto H; Ohashi T; Sakamoto R
    J Clin Pharm Ther; 2016 Jun; 41(3):290-7. PubMed ID: 27109450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gout.
    Messerli FH; Makani H; Halpern D
    N Engl J Med; 2011 May; 364(19):1876-7; author reply 1877. PubMed ID: 21561363
    [No Abstract]   [Full Text] [Related]  

  • 14. A controlled study of the effect of long term allopurinol treatment on renal function in gout.
    Gibson T; Simmonds HA; Potter C; Rogers V
    Adv Exp Med Biol; 1980; 122A():257-62. PubMed ID: 6999847
    [No Abstract]   [Full Text] [Related]  

  • 15. Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol.
    Stamp LK; Taylor WJ; Jones PB; Dockerty JL; Drake J; Frampton C; Dalbeth N
    Arthritis Rheum; 2012 Aug; 64(8):2529-36. PubMed ID: 22488501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.
    Dalbeth N; Kumar S; Stamp L; Gow P
    J Rheumatol; 2006 Aug; 33(8):1646-50. PubMed ID: 16783857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of gout.
    Cohen MG
    Intern Med J; 2011 Jan; 41(1a):70-1. PubMed ID: 21265967
    [No Abstract]   [Full Text] [Related]  

  • 18. Gout and uric acid metabolism.
    Arthritis Rheum; 1970; 13(5):553-69. PubMed ID: 4922854
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of daily single doses of 300 mg allopurinol on serum uric acid concentration and urate excretion in gouty patients (author's transl)].
    Matzkies F; Berg G
    Dtsch Med Wochenschr; 1974 Nov; 99(48):2464-5. PubMed ID: 4448143
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effects of allopurinol in gout patients with uric urinary lithiasis or hyperuraturia].
    Delbarre F; Foglierini J; Larrieu F; Frugier JC
    Sem Hop; 1967 Feb; 43(10):652-8. PubMed ID: 4292984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.